about
Detectable clonal mosaicism and its relationship to aging and cancerEpigenomics of leukemia: from mechanisms to therapeutic applicationsThe potential of venetoclax (ABT-199) in chronic lymphocytic leukemiaDetectable clonal mosaicism from birth to old age and its relationship to cancerCD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCγ1 activation: evidence from mice and humansTranslocation t(2;11) in CLL cells results in CXCR4/MAML2 fusion oncogene.Congenital B cell lymphocytosis explained by novel germline CARD11 mutations.Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation.TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemia.Acidosis Sensing Receptor GPR65 Correlates with Anti-Apoptotic Bcl-2 Family Member Expression in CLL Cells: Potential Implications for the CLL MicroenvironmentPTPROt-mediated regulation of p53/Foxm1 suppresses leukemic phenotype in a CLL mouse modelGenome-wide association study of lung function decline in adults with and without asthma.Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 family.Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic and molecular study.A Sleeping Beauty screen reveals NF-kB activation in CLL mouse modelLipoprotein lipase: a new prognostic factor in chronic lymphocytic leukaemiaDysregulation of a family of short noncoding RNAs, tsRNAs, in human cancer.Molecular pathogenesis of CLL and its evolution.The long journey of TCL1 transgenic mice: lessons learned in the last 15 years.Exonal switch down regulates the expression of CD5 on blasts of acute T cell leukemia.Common nonmutational NOTCH1 activation in chronic lymphocytic leukemia.Aging and the rise of somatic cancer-associated mutations in normal tissues.Microenvironmental stromal cells abrogate NF-κB inhibitor-induced apoptosis in chronic lymphocytic leukemia.Expression and regulation of CacyBP/SIP in chronic lymphocytic leukemia cell balances of cell proliferation with apoptosis.Chemotactic Cues for NOTCH1-Dependent Leukemia.Non-coding recurrent mutations in chronic lymphocytic leukaemia
P2860
Q23916196-67C20B69-2499-4B46-98D5-B84973C3E5ADQ26823403-8A099319-593C-4CDA-8A78-E65CF4606CA1Q28075504-A3FA7F9E-99C6-454E-BC8D-9CC4BC7EB61EQ28385149-87BAFC21-A2B4-44D5-B705-31E658A30B0BQ28543785-8443700E-D6EB-4C8A-96C2-46D2FB06660BQ33886894-32EF63FB-36F0-451E-AF33-2767C04851DFQ34310172-9FCD1A95-E9C3-406B-96E9-15D9199FBE61Q35125652-0FC03A81-9135-4378-80D8-ECFFF3391C50Q35128888-206B3FAF-7C21-47DA-A73F-7748DA821844Q35606359-905D7D11-0FDD-4638-9A81-431D8C5FA4AEQ35685290-47361FB1-F10B-4D74-9545-BBC5B6D37424Q35923186-FB543A77-0FA6-468D-98D8-E8228C53B232Q36405766-D51E4C2E-23A7-4019-A058-28CD44A75FBCQ36806417-DD9DAAEB-2218-42C7-941B-79E87BAE031AQ36873288-7D213E6E-8C07-477C-AF12-977BFB79C6E9Q36942667-7AEB55A1-A660-439D-B3EB-DDB66914A65FQ37173032-C3813D16-CF6E-4257-A3E3-95697848BF89Q38335695-B8B7BA7B-9956-4F12-8EB5-A5D20580A172Q38362950-9D68756E-40FE-430F-8240-4279A6889F22Q38655954-73F57474-B31F-4FD3-9F84-C525F596CA1FQ42291852-BDFDA9F0-F504-4A09-81E9-61092F4CF952Q48309999-C3F6A7C1-0E05-49F5-AC4C-18229C5C024DQ49196241-89AF7055-A574-4BF5-8A9B-CBA02988582CQ52900621-6998DAD1-015D-4209-8BC4-C90272E3140AQ55235440-63B57A44-F5EE-4DB6-A61A-A3F1E09FBD53Q56996904-AB94BF13-0234-438A-9403-76089B41CEB3
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular basis of CLL
@en
Molecular basis of CLL.
@nl
type
label
Molecular basis of CLL
@en
Molecular basis of CLL.
@nl
prefLabel
Molecular basis of CLL
@en
Molecular basis of CLL.
@nl
P2860
P1476
Molecular basis of CLL
@en
P2093
Nicola Zanesi
Yuri Pekarsky
P2860
P304
P356
10.1016/J.SEMCANCER.2010.09.003
P577
2010-09-21T00:00:00Z